What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Cancer
His primary scientific interests are in Internal medicine, Gastroenterology, Immunology, Hepatitis C and Hepatitis B virus.
The Internal medicine study combines topics in areas such as Pegylated interferon, Ribavirin, Hepatitis C virus and Surgery.
His Hepatitis C virus study combines topics from a wide range of disciplines, such as Steatosis and Genotype.
His research in Gastroenterology intersects with topics in Fibrosis, Liver biopsy and Peginterferon alfa-2a.
His work investigates the relationship between Hepatitis C and topics such as Simeprevir that intersect with problems in Daclatasvir.
In his study, Lamivudine, Viral load and Viral hepatitis is inextricably linked to Hepatitis B, which falls within the broad field of Hepatitis B virus.
His most cited work include:
- Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (2656 citations)
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (2258 citations)
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection (2132 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Gastroenterology, Immunology, Virology and Hepatitis C virus.
His studies in Internal medicine integrate themes in fields like Ribavirin and Hepatitis B virus.
Patrick Marcellin has included themes like Fibrosis, Chronic hepatitis, Surgery and Peginterferon alfa-2a in his Gastroenterology study.
His Virology research incorporates elements of Polymerase chain reaction and Genotype.
Patrick Marcellin combines subjects such as Antibody and Liver biopsy with his study of Hepatitis C virus.
His Hepatitis C study combines topics in areas such as Prospective cohort study and Steatosis.
He most often published in these fields:
- Internal medicine (60.56%)
- Gastroenterology (48.45%)
- Immunology (35.87%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (60.56%)
- Gastroenterology (48.45%)
- Hepatitis B virus (20.03%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Gastroenterology, Hepatitis B virus, Hepatitis B and HBsAg are his primary areas of study.
His studies deal with areas such as HBeAg and Ribavirin as well as Internal medicine.
His Gastroenterology study incorporates themes from Surgery and Hepatitis C virus.
His work deals with themes such as Discontinuation and Combination therapy, which intersect with Hepatitis B virus.
His Hepatitis B research also works with subjects such as
- Viral load which intersects with area such as Hepatitis,
- Adefovir which intersects with area such as Young adult.
His HBsAg study is related to the wider topic of Immunology.
Between 2014 and 2021, his most popular works were:
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis (296 citations)
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications (258 citations)
- Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS) (222 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Cancer
His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Hepatocellular carcinoma and Hepatitis B virus.
His work on Ribavirin expands to the thematically related Internal medicine.
His Gastroenterology research integrates issues from Surgery, Hepatitis C virus, HBsAg, HBeAg and Hepatitis C.
The study incorporates disciplines such as Stage, Liver biopsy and Fibrosis in addition to HBeAg.
While the research belongs to areas of Cirrhosis, Patrick Marcellin spends his time largely on the problem of Liver disease, intersecting his research to questions surrounding Decompensation.
Patrick Marcellin interconnects Prothrombin time and Cohort in the investigation of issues within Hepatocellular carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
